The urine lipoarabinomannan tuberculosis LAM test was launched in 2015; the test is for active TB diagnosis in HIV‐infected persons with severe immunosuppression (CD4 < 200 cells/μL) [50]. This evidence concerns the gene CD4 and tuberculosis.